报价延迟最少15分钟:2025/11/07 05:35 EST
盘前时段
|
||||
|
0.6511 
|
|
|
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
0.675
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-0.40/--
|
|
企业价值
574.44M
|
| 资产负债 |
|
每股账面净值
3.88
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
报价延迟最少15分钟：2025/11/07 05:35 EST
同行比较之报价最少15分钟延迟
|
业务概览
|
|||
| OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea. |
